Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts

23 Jun 2020

Abstract excerpt

Publisher's Note: There is a Blood Commentary on this article in this issue.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32575123
DOI: 10.1182/blood.2020006113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenograftsPMID 32575123Read ↗

Potent inhibition of DOT1L as treatment of MLL-fusion leukemiaSemantic proximity Read ↗

An update on DOT1LWT/MUT modulators as a promising anticancer strategy.Semantic proximity Read ↗

Molecular pathways: protein methyltransferases in cancer.Semantic proximity Read ↗

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance.Semantic proximity Read ↗

The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsivenessSemantic proximity Read ↗

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AMLSemantic proximity Read ↗

Designing Effective Protein Lysine and Arginine Methyltransferase Inhibitors for Chemotherapeutic TargetingSemantic proximity Read ↗

MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibitionSemantic proximity Read ↗

The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPNSemantic proximity Read ↗

DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.Semantic proximity Read ↗

DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.Semantic proximity Read ↗

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.